Point72 Asset Management, L.P. 13D and 13G filings for Corvus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-09 5:29 pm Purchase | 2024-05-02 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Point72 Asset Management, L.P. | 17,050,384 9.900% | 17,050,384 (New Position) | Filing |